July 22, 2019 – Ann Hardy's transformational donation led to the development of the first drug effective against FIP. Learn more about Ann's life and legacy.
July 22, 2019 – Foundation-funded researchers found endocrine-disrupting chemicals (EDCs) may play a role in the development of equine metabolic syndrome (EMS).
July 17, 2018 – Find out about our planned giving Lamplighter) program from Kathy O'Neil, Lamplighter, Golden Retriever Lifetime Study participant and Foundation supporter.